推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

JOURNAL OF CLINICAL ONCOLOGY

2023年12月最新中科院分区表数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 J CLIN ONCOL最新评论:请问under review 是在外审吗 (2024-01-29)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中科院分区:   是否OA期刊:   结果排序:

同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


JOURNAL OF CLINICAL ONCOLOGY期刊基本信息Hello,您是该期刊的第88924位访客

基本信息 登录收藏
期刊名字JOURNAL OF CLINICAL ONCOLOGYJOURNAL OF CLINICAL ONCOLOGY

J CLIN ONCOL
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
9.9
50人评分
我要评分

声誉
10.0

影响力
9.9

速度
9.4

期刊ISSN0732-183X
微信扫码收藏此期刊
E-ISSN1527-7755
2022-2023最新影响因子
(数据来源于搜索引擎)
45.3 点击查看影响因子趋势图
实时影响因子 截止2024年3月26日:24.33
2022-2023自引率2.20%点击查看自引率趋势图
五年影响因子37.6
h-index 494
CiteScore
CiteScoreSJRSNIPCiteScore排名
39.6010.1636.449
学科分区排名百分位
大类:Biochemistry, Genetics and Molecular Biology
小类:Cancer Research
Q15 / 214
大类:Biochemistry, Genetics and Molecular Biology
小类:Oncology
Q19 / 366

期刊简介
The Journal of Clinical Oncology serves its readers as the single most credible, authoritative resource for disseminating significant clinical oncology research. In print and in electronic format, JCO strives to publish the highest quality articles dedicated to clinical research. Original Reports remain the focus of JCO, but this scientific communication is enhanced by appropriately selected Editorials, Commentaries, Reviews, and other work that relate to the care of patients with cancer.

Print ISSN: 0732-183X
期刊官方网站http://jco.ascopubs.org/
期刊投稿网址https://www.editorialmanager.com/JCO-ASCOPUBS
期刊语言要求经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足JOURNAL OF CLINICAL ONCOLOGY的语言要求,还能让JOURNAL OF CLINICAL ONCOLOGY编辑和审稿人得到更好的审稿体验,让稿件最大限度地被JOURNAL OF CLINICAL ONCOLOGY编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问No
通讯方式AMER SOC CLINICAL ONCOLOGY, 2318 MILL ROAD, STE 800, ALEXANDRIA, USA, VA, 22314
出版商American Society of Clinical Oncology
涉及的研究方向医学-肿瘤学
出版国家或地区UNITED STATES
出版语言English
出版周期Biweekly
出版年份1983
年文章数 340点击查看年文章数趋势图
Gold OA文章占比25.40%
研究类文章占比:
文章 ÷(文章 + 综述)
87.35%
WOS期刊SCI分区
2022-2023年最新版
WOS分区等级:1区

按学科分区JIF分区JIF排名JIF百分位
学科:ONCOLOGY
类别:SCIE
Q17/241
中科院《国际期刊预警
名单(试行)》名单
2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中科院SCI期刊分区
2023年12月最新升级版
点击查看中科院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 3区1区3区
ONCOLOGY
肿瘤学
2区3区1区
中科院SCI期刊分区
2022年12月升级版
大类学科小类学科Top期刊综述期刊
医学 1区1区1区
ONCOLOGY
肿瘤学
2区2区1区
中科院SCI期刊分区
2021年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 3区1区3区
ONCOLOGY
肿瘤学
4区3区1区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0732-183X%5BISSN%5D
平均审稿速度网友分享经验:
平均2月
平均录用比例网友分享经验:
约20%
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在JOURNAL OF CLINICAL ONCOLOGY顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 JOURNAL OF CLINICAL ONCOLOGY期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 JOURNAL OF CLINICAL ONCOLOGY中科院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
JOURNAL OF CLINICAL ONCOLOGY上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中科院SCI期刊分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发表论文
  • 中科院SCI期刊分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144642.90
    Nature Reviews Clinical Oncology12775.50
    NATURE REVIEWS CANCER39696.70
    LANCET ONCOLOGY27462.00
    ANNALS OF ONCOLOGY21063.00
    CANCER CELL29552.90
    SEMINARS IN CANCER BIOLOGY13420.00
    CANCER TREATMENT REVIEWS11620.70
    CLINICAL CANCER RESEARCH29221.80
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH6720.70
    中科院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE604325
    BIOMATERIALS515921
    BIOMEDICINE & PHARMACOTHERAPY467084
    Journal of Materials Chemistry B461401
    Frontiers in Pharmacology452333
    Frontiers in Immunology423969
    JOURNAL OF ETHNOPHARMACOLOGY407600
    COLLOIDS AND SURFACES B-BIOINTERFACES405377
    Frontiers in Oncology385898
    Acta Biomaterialia377520
  •  

    JOURNAL OF CLINICAL ONCOLOGY JOURNAL OF CLINICAL ONCOLOGY
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH)

    Author: Peng, Zhenwei; Fan, Wenzhe; Zhu, Bowen; Wang, Guoying; Sun, Junhui; Xiao, Chengjiang; Huang, Fuxi; Tang, Rong; Cheng, Yu; Huang, Zhen; Liang, Yuchuang; Fan, Huishuang; Qiao, Liangliang; Li, Fuliang; Zhuang, Wenquan; Peng, Baogang; Wang, Jiping; Li, Jiaping; Kuang, Ming
    Journal: JOURNAL OF CLINICAL ONCOLOGY. 2023; Vol. 41, Issue 1, pp. 117-+. DOI: 10.1200/JCO.22.00392
        PubMed      DOI
    2.Busulfan Plus Cyclophosphamide Versus Total Body Irradiation Plus Cyclophosphamide for Adults Acute B Lymphoblastic Leukemia: An Open-Label, Multicenter, Phase III Trial

    Author: Zhang, Haiyan; Fan, Zhiping; Huang, Fen; Han, Lijie; Xu, Yajing; Xu, Na; Deng, Lan; Wang, Shunqing; Lin, Dongjun; Luo, Xiaodan; Zhang, Qing; Liu, Xiaodan; Li, Xudong; Liang, Xinquan; Xie, Shuangfeng; Qu, Hong; Yu, Sijian; Zhou, Hongsheng; Shi, Pengcheng; Xuan, Li; Lin, Ren; Liu, Hui; Jin, Hua; Sun, Jing; Liu, Qifa
    Journal: JOURNAL OF CLINICAL ONCOLOGY. 2023; Vol. 41, Issue 2, pp. 343-+. DOI: 10.1200/JCO.22.00767
        PubMed      DOI
    3.Selpercatinib in Patients With RET Fusion-Positive Non-Small-Cell Lung Cancer: Updated Safety and Efficacy From the Registrational LIBRETTO-001 Phase I/II Trial

    Author: Drilon, Alexander; Subbiah, Vivek; Gautschi, Oliver; Tomasini, Pascale; de Braud, Filippo; Solomon, Benjamin J.; Tan, Daniel Shao-Weng; Alonso, Guzman; Wolf, Juergen; Park, Keunchil; Goto, Koichi; Soldatenkova, Victoria; Szymczak, Sylwia; Barker, Scott S.; Puri, Tarun; Bence Lin, Aimee; Loong, Herbert; Besse, Benjamin
    Journal: JOURNAL OF CLINICAL ONCOLOGY. 2023; Vol. 41, Issue 2, pp. 385-+. DOI: 10.1200/JCO.22.00393
        PubMed      DOI
    4.Toripalimab Plus Chemotherapy for Patients With Treatment-Naive Advanced Non-Small-Cell Lung Cancer: A Multicenter Randomized Phase III Trial (CHOICE-01)

    Author: Wang, Zhijie; Wu, Lin; Li, Baolan; Cheng, Ying; Li, Xiaoling; Wang, Xicheng; Han, Liang; Wu, Xiaohong; Fan, Yun; Yu, Yan; Lv, Dongqing; Shi, Jianhua; Huang, Jianjin; Zhou, Shaozhang; Han, Baohui; Sun, Guogui; Guo, Qisen; Ji, Youxin; Zhu, Xiaoli; Hu, Sheng; Zhang, Wei; Wang, Qiming; Jia, Yuming; Wang, Ziping; Song, Yong; Wu, Jingxun; Shi, Meiqi; Li, Xingya; Han, Zhigang; Liu, Yunpeng; Yu, Zhuang; Liu, An-Wen; Wang, Xiuwen; Zhou, Caicun; Zhong, Diansheng; Miao, Liyun; Zhang, Zhihong; Zhao, Hui; Yang, Jun; Wang, Dong; Wang, Yingyi; Li, Qiang; Zhang, Xiaodong; Ji, Mei; Yang, Zhenzhou; Cui, Jiuwei; Gao, Beili; Wang, Buhai; Liu, Hu; Nie, Lei; He, Mei; Jin, Shi; Gu, Wei; Shu, Yongqian; Zhou, Tong; Feng, Jian; Yang, Xinmei; Huang, Cheng; Zhu, Bo; Yao, Yu; Tang, Xiongwen; Yu, Jianjun; Maher, Ellen; Feng, Hui; Yao, Sheng; Keegan, Patricia; Wang, Jie
    Journal: JOURNAL OF CLINICAL ONCOLOGY. 2023; Vol. 41, Issue 3, pp. 651-+. DOI: 10.1200/JCO.22.00727
        PubMed      DOI
    5.BRCA-CRisk: A Contralateral Breast Cancer Risk Prediction Model for BRCA Carriers

    Author: Sun, Jie; Chu, Futao; Pan, Jiani; Zhang, Yaxin; Yao, Lu; Chen, Jiuan; Hu, Li; Zhang, Juan; Xu, Ye; Wang, Xiaojia; Cao, Wenming; Xie, Yuntao
    Journal: JOURNAL OF CLINICAL ONCOLOGY. 2023; Vol. 41, Issue 5, pp. 991-+. DOI: 10.1200/JCO.22.00833
        PubMed      DOI
    6.Zanubrutinib Versus Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: Interim Analysis of a Randomized Phase III Trial

    Author: Hillmen, Peter; Eichhorst, Barbara; Brown, Jennifer R.; Lamanna, Nicole; O'Brien, Susan M.; Tam, Constantine S.; Qiu, Lugui; Kazmierczak, Maciej; Zhou, Keshu; Simkovic, Martin; Mayer, Jiri; Gillespie-Twardy, Amanda; Shadman, Mazyar; Ferrajoli, Alessandra; Ganly, Peter S.; Weinkove, Robert; Grosicki, Sebastian; Mital, Andrzej; Robak, Tadeusz; Osterborg, Anders; Yimer, Habte A.; Salmi, Tommi; Ji, Meng; Yecies, Jessica; Idoine, Adam; Wu, Kenneth; Huang, Jane; Jurczak, Wojciech
    Journal: JOURNAL OF CLINICAL ONCOLOGY. 2023; Vol. 41, Issue 5, pp. 1035-+. DOI: 10.1200/JCO.22.00510
        PubMed      DOI
    7.Pembrolizumab Versus Placebo as Second-Line Therapy in Patients From Asia With Advanced Hepatocellular Carcinoma: A Randomized, Double-Blind, Phase III Trial

    Author: Qin, Shukui; Chen, Zhendong; Fang, Weijia; Ren, Zhenggang; Xu, Ruocai; Ryoo, Baek-Yeol; Meng, Zhiqiang; Bai, Yuxian; Chen, Xiaoming; Liu, Xiufeng; Xiao, Juxiang; Ho, Gwo Fuang; Mao, Yimin; Wang, Xin; Ying, Jieer; Li, Jianfeng; Zhong, Wenyan; Zhou, Yu; Siegel, Abby B.; Hao, Chunyi
    Journal: JOURNAL OF CLINICAL ONCOLOGY. 2023; Vol. 41, Issue 7, pp. 1434-+. DOI: 10.1200/JCO.22.00620
        PubMed      DOI
    8.Effect of Pregabalin on Radiotherapy-Related Neuropathic Pain in Patients With Head and Neck Cancer: A Randomized Controlled Trial.

    Author: Jiang J1, Li Y1, Shen Q1,2, Rong X1, Huang X1, Li H1, Zhou L3, Mai HQ4, Zheng D5, Chen MY4, Xu Y1, Li J4, Hui X6, Simone CB 2nd7, Gaertner J8, Argyriou AA9, Chow E10, Chen P3, Tang Y1.
    Journal: J Clin Oncol. 2019 Jan 10;37(2):135-143. doi: 10.1200/JCO.18.00896. Epub 2018 Nov 20.
        PubMed      DOI
    9.PHOENIX-GC Trial: Underpowered for Significant Results?

    Author: Li Z1, Xue K1, Ying X1, Ji J1.
    Journal: J Clin Oncol. 2019 Jan 10;37(2):167. doi: 10.1200/JCO.18.00364. Epub 2018 Nov 26.
        PubMed      DOI
    10.Is SLFN11 a Promising Predictive Biomarker of Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Small-Cell Lung Cancer? Not Yet!

    Author: Liang F1.
    Journal: J Clin Oncol. 2019 Jan 20;37(3):259. doi: 10.1200/JCO.18.00993. Epub 2018 Nov 29.
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144642.90
    LANCET700133.20
    NEW ENGLAND JOURNAL OF MEDICINE933134.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION62245.40
    NATURE REVIEWS DRUG DISCOVERY289123.80
    BMJ-British Medical Journal015.30
    BMJ-British Medical Journal015.30
    NATURE REVIEWS IMMUNOLOGY35183.00
    NATURE MEDICINE497107.50
    Nature Reviews Disease Primers4860.90
    同分区等级的其他期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144642.90
    LANCET700133.20
    NEW ENGLAND JOURNAL OF MEDICINE933134.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION62245.40
    NATURE REVIEWS DRUG DISCOVERY289123.80
    NATURE REVIEWS MOLECULAR CELL BIOLOGY386164.40
    BMJ-British Medical Journal015.30
    BMJ-British Medical Journal015.30
    NATURE REVIEWS IMMUNOLOGY35183.00
    NATURE REVIEWS MICROBIOLOGY25060.20


以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

    同领域作者分享投稿经验:共87条 (包含回复)

我来分享

    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海分公司    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960

    增值电信业务经营许可证:沪B2-20211595

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室

    United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451